A neural-related gene risk score for head and neck squamous cell carcinoma.
Zhuo-Ying TaoWei-Fa YangWang-Yong ZhuLei-Lei WangKar Yan LiXin-Yuan GuanYu-Xiong Richard SuPublished in: Oral diseases (2022)
NRGRS strongly correlates with survival and is a promising biomarker to predict immunotherapy benefits for head and neck cancer patients. This study provides evidence for the potential correlation between neural-related transcriptome alteration and immune activity.